MX354598B - Uso de neuregulina para tratar lesion de nervio periferico. - Google Patents

Uso de neuregulina para tratar lesion de nervio periferico.

Info

Publication number
MX354598B
MX354598B MX2014011838A MX2014011838A MX354598B MX 354598 B MX354598 B MX 354598B MX 2014011838 A MX2014011838 A MX 2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A MX 354598 B MX354598 B MX 354598B
Authority
MX
Mexico
Prior art keywords
peripheral nerve
nerve injury
neuregulin
treat peripheral
treat
Prior art date
Application number
MX2014011838A
Other languages
English (en)
Other versions
MX2014011838A (es
Inventor
Anthony O Caggiano
Anindita Ganguly
Jennifer Iaci
Anthony J Bella
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of MX2014011838A publication Critical patent/MX2014011838A/es
Publication of MX354598B publication Critical patent/MX354598B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende una cantidad eficaz de una neuregulina para usarse en la disminución de dolor neuropático en un sujeto en riesgo de sufrir una lesión de nervio periférico debido a un procedimiento quirúrgico.
MX2014011838A 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico. MX354598B (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693589P 2012-08-27 2012-08-27
US201261693585P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury

Publications (2)

Publication Number Publication Date
MX2014011838A MX2014011838A (es) 2015-03-09
MX354598B true MX354598B (es) 2018-03-12

Family

ID=48128617

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011838A MX354598B (es) 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico.

Country Status (16)

Country Link
US (3) US20150094263A1 (es)
EP (3) EP3842059A1 (es)
JP (4) JP6420233B2 (es)
CN (2) CN106511971A (es)
AU (4) AU2013237896B2 (es)
BR (1) BR112014024308B1 (es)
CA (1) CA2869070A1 (es)
DK (2) DK2830645T3 (es)
ES (2) ES2647917T3 (es)
HK (2) HK1206632A1 (es)
IL (3) IL288785B2 (es)
MX (1) MX354598B (es)
NZ (1) NZ700546A (es)
PL (2) PL2830645T3 (es)
PT (2) PT2830645T (es)
WO (1) WO2013149163A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5797112B2 (ja) 2008-07-17 2015-10-21 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはそのサブ配列の治療的投与方法
WO2011047183A2 (en) 2009-10-14 2011-04-21 Acorda Therapeutics, Inc. Use of a neuregulin to treat peripheral nerve injury
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
IL294038A (en) * 2015-12-04 2022-08-01 Univ Iowa Res Found Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium
CA3082878C (en) 2017-11-17 2024-02-20 The Research Foundation for State University of New York A method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
US20220277853A1 (en) * 2019-08-01 2022-09-01 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
AU745324B2 (en) * 1997-10-14 2002-03-21 Cenes Pharmaceuticals, Inc. Therapeutic methods comprising use of a neuregulin
JP5324732B2 (ja) * 2000-05-23 2013-10-23 スネス ファーマシューティカルズ インコーポレイテッド Ｎｒｇ−２核酸分子、ポリペプチド、ならびに診断および治療法
WO2009046453A2 (en) * 2007-10-05 2009-04-09 New England Medical Center (Nemc) Use of neuregulin-1 in reducing brain damage
ES2811127T3 (es) * 2008-02-29 2021-03-10 Acorda Therapeutics Inc Composiciones para lograr niveles plasmáticos deseados del factor 2 de crecimiento glial
JP5797112B2 (ja) * 2008-07-17 2015-10-21 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはそのサブ配列の治療的投与方法
JP5826742B2 (ja) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド 神経損傷及び神経疾患の予防または治療用薬学組成物
WO2011047183A2 (en) * 2009-10-14 2011-04-21 Acorda Therapeutics, Inc. Use of a neuregulin to treat peripheral nerve injury
US20130143805A1 (en) * 2010-08-13 2013-06-06 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
AU2013237896B2 (en) 2017-11-02
ES2647917T3 (es) 2017-12-27
DK3278811T3 (da) 2021-03-01
AU2019202401A1 (en) 2019-05-02
PT3278811T (pt) 2021-03-03
WO2013149163A1 (en) 2013-10-03
IL288785B2 (en) 2023-03-01
US20230117985A1 (en) 2023-04-20
HK1249038A1 (zh) 2018-10-26
IL273186A (en) 2020-04-30
JP2015514096A (ja) 2015-05-18
BR112014024308B1 (pt) 2021-11-30
CA2869070A1 (en) 2013-10-03
AU2013237896A1 (en) 2014-10-16
JP7108724B2 (ja) 2022-07-28
EP3278811A1 (en) 2018-02-07
EP2830645B1 (en) 2017-08-30
MX2014011838A (es) 2015-03-09
IL273186B (en) 2022-01-01
ES2857810T3 (es) 2021-09-29
CN104321072A (zh) 2015-01-28
AU2018200592A1 (en) 2018-02-15
BR112014024308A8 (pt) 2018-01-23
AU2019202401B2 (en) 2020-10-15
IL234882A0 (en) 2014-12-31
US20160346353A1 (en) 2016-12-01
BR112014024308A2 (pt) 2017-08-08
PL2830645T3 (pl) 2018-01-31
PT2830645T (pt) 2017-11-28
PL3278811T3 (pl) 2021-08-02
JP2017149746A (ja) 2017-08-31
NZ700546A (en) 2017-05-26
JP6420233B2 (ja) 2018-11-07
HK1206632A1 (en) 2016-01-15
US20150094263A1 (en) 2015-04-02
DK2830645T3 (da) 2017-11-20
CN106511971A (zh) 2017-03-22
IL288785B (en) 2022-11-01
JP2021059605A (ja) 2021-04-15
EP3278811B1 (en) 2020-12-02
EP2830645A1 (en) 2015-02-04
JP2019131582A (ja) 2019-08-08
IL288785A (en) 2022-02-01
EP3842059A1 (en) 2021-06-30
AU2020260539A1 (en) 2020-11-26
IL234882B (en) 2020-03-31

Similar Documents

Publication Publication Date Title
MX354598B (es) Uso de neuregulina para tratar lesion de nervio periferico.
MX2014010455A (es) Metodos y composiciones para tratar enfermedad de huntington.
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
PH12015500525A1 (en) Formulations of enzalutamide
IN2015DN00438A (es)
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
IN2014DN09782A (es)
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
TN2015000385A1 (en) Peptides and compositions for treatment of joint damage
MX2013015158A (es) Compuestos inhibidores de metaloenzima.
IN2014DN06792A (es)
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
MX348040B (es) Antagonistas de hedgehog que tienen residuos que se unen al zinc.
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MX2015000804A (es) Composiciones y metodos para tratar el sarcoma de ewing y otros trastornos relacionados con ews-fli1.
MX362111B (es) Un metodo para mejorar la funcion hepatica.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration